All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Myasthenia gravis, castleman disease, pemphigus, and anti-phospholipid syndrome

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10188935" target="_blank" >RIV/00216208:11110/13:10188935 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216275:25520/13:39896437 RIV/00064203:_____/13:10188935 RIV/00064165:_____/13:10188935

  • Result on the web

    <a href="http://dx.doi.org/10.1002/mus.23657" target="_blank" >http://dx.doi.org/10.1002/mus.23657</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/mus.23657" target="_blank" >10.1002/mus.23657</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Myasthenia gravis, castleman disease, pemphigus, and anti-phospholipid syndrome

  • Original language description

    Introduction: Myasthenia gravis is an autoimmune disease marked by neuromuscular transmission failure at the neuromuscular junction. Castleman disease is a rare lymphoproliferative disease characterized by non-cancerous angiofolicular hyperplasia of lymphatic tissue. Methods and results: We describe a young man with rapid, successive manifestations of myasthenia gravis, a solitary form of Castleman disease, pemphigus vulgaris, and anti-phospholipid syndrome, which resulted in 2 ischemic cerebrovascularevents that caused a severe central neurological deficit. Discussion: We were unable to find a similar case in the literature, but we hypothesize that the temporal concidence of these clinical entities may be related to a common immunological pathway, such as B-cell activation. Therefore, we treated the patient with an immunosuppressant and anticoagulant treatment, as well as rituximab, a monoclonal antibody therapy against CD20+. Muscle Nerve 47:447-451, 2013

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Muscle and Nerve

  • ISSN

    0148-639X

  • e-ISSN

  • Volume of the periodical

    47

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    5

  • Pages from-to

    447-451

  • UT code for WoS article

    000315401500021

  • EID of the result in the Scopus database